Cryoport, Inc. (CYRX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated April 29, 2022, details the results of Cryoport, Inc.'s 2022 Annual Meeting of Stockholders. The company is incorporated in Nevada and its common stock trades on The NASDAQ Stock Market LLC under the symbol "CYRX."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes rather than financial performance data.
Material Changes and Voting Results
The following proposals were submitted to and voted upon by stockholders:
- Proposal 1: Election of Directors. All eight nominees were elected to serve until the 2023 Annual Meeting. Notable voting statistics include:
- Richard Berman: 33,434,694 votes for; 11,170,500 votes withheld.
- Robert Hariri, M.D., Ph.D.: 31,954,211 votes for; 12,650,983 votes withheld.
- Ramkumar Mandalam, Ph.D.: 31,536,273 votes for; 13,068,921 votes withheld.
- Other Nominees: Received significant support with withheld votes ranging from approximately 723,000 to 1.2 million.
- Proposal 2: Ratification of Auditors. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2022, was approved with 48,042,299 votes for and only 6,749 votes against.
- Proposal 3: Executive Compensation. The advisory vote to approve the compensation of named executive officers was approved with 43,353,996 votes for and 1,237,797 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the final tally of the annual meeting votes.
Key Facts for Investor Verification
- Verify the specific reasons for the higher number of "votes withheld" for directors Richard Berman, Robert Hariri, and Ramkumar Mandalam compared to other nominees.
- Confirm the total number of shares outstanding and the quorum status at the time of the meeting to contextualize the vote counts.
- Review the March 18, 2022 Proxy Statement referenced in the filing for detailed biographies of the elected directors and the full compensation discussion for Proposal 3.
- Check subsequent filings for the company's financial results, as this 8-K contains no financial data.